Plasmion and Waters – Co-Marketing Agreement
PLASMION AND WATERS CORPORATION SIGN A CO-MARKETING AND CO-PROMOTION AGREEMENT TO ENHANCE AND SIMPLIFY CHEMICAL ANALYSIS
Companies agree to make Plasmion SICRIT® ion source compatible with Waters ACQUITY™ QDa™ Detector and SELECT SERIES™
Cyclic IMS™ mass spectrometers
Augsburg, February 21, 2024 – Plasmion has announced it has signed a co-marketing and co-promotion agreement with Waters Corporation to enhance analytical technologies used in scientific laboratories and Applied Markets, to help
advance human health and well-being.
Through their agreement, the companies have ensured compatibility of Plasmion’s SICRIT® ion source with the Waters ACQUITY™ QDa™ Detector and SELECT SERIES™ Cyclic IMS™ mass spectrometers to contribute in advancing research in the Applied Markets and Life Sciences.
Dr. Thomas Wolf, CEO of Plasmion:
„Through our joint activities, we will contribute to advancing research and development, helping scientists make essential analyses significantly simpler, faster, and more secure. Providing simple Plug & Play solutions for Point-of-Need Analytics applications makes scientific technology accessible to a broader audience in the Applied Markets.“
Gary Harland, Senior Director and Portfolio Owner, Discovery and Development, Waters Corporation:
“Combining Plasmion’s SICRIT® direct ionization source with Waters mass spectrometry instruments opens many new analytical possibilities for at-point applications. These include process optimization and process monitoring, as well as online direct detection of potential biomarkers in emerging areas of metabolomics. It’s a simple, efficient, and powerful addition to our instruments that offers customers an advanced tool for real-time analysis of chemical components and biomedical samples.”
Plasmion’s innovative and unique ionization technology, SICRIT®, enables users to simplify chemical analysis and has the potential to make mass spectrometry more accessible. The unique flow-through ionization technology features analysis with a broader spectrum of analytes, little to no fragmentation, and high sensitivity.
SICRIT® can be coupled to Waters instruments such as ACQUITY QDa Detector and SELECT SERIES Cyclic IMS systems and enables users to conduct direct mass spectrometry in a quantitative manner, significantly speeding up analysis processes. Amongst other applications, this also enables the direct analysis of human breath for biomarker discovery. If samples require it, SICRIT® also allows coupling with any kind of chromatography (GC, LC, SFC, etc.) to the mass spectrometer, providing customers with ultimate flexibility.
A technical partnership with Waters opens new opportunities for advanced chemical detection in Applied Markets and aims to improve technology for human health and well-being.
Plasmion, headquartered in Augsburg, Germany, strives to simplify mass spectrometry and bridging from laboratory precision to industrial workflows. After introducing it to the market in 2018, their SICRIT® technology not only revolutionizes chemical analysis in the lab, but also makes it possible to use mass spectrometers as automated VOC sensors in industrial environments.